Does neutrophil-to-lymphocyte ratio have a role among the other prognostic factors of nonsmall cell lung cancer?

Yildirim F., Sevimli N., Turk M., YILMAZ DEMİRCİ N., YURDAKUL A. S., ÖZTÜRK C.

EURASIAN JOURNAL OF PULMONOLOGY, cilt.21, sa.3, ss.187-192, 2019 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4103/ejop.ejop_2_19
  • Dergi Adı: EURASIAN JOURNAL OF PULMONOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.187-192
  • Anahtar Kelimeler: Neutrophil-to-lymphocyte ratio, non-small cell lung cancer, prognosis, INFLAMMATION, STATISTICS, SURVIVAL, MARKER, IMPACT, NLR
  • Gazi Üniversitesi Adresli: Evet

Özet

INTRODUCTION: Neutrophil-to-lymphocyte ratio (NLR), an index of systemic inflammation, has been associated with poor survival for many cancers. The aim of this study was to investigate the clinical significance of blood NLR in nonsmall cell lung cancer (NSCLC) as a prognostic factor.